Who Wants to Switch? Gauging Patient Interest in Novel Antiretroviral Therapies

Study participants were asked about their interest in switching to novel drug delivery systems that reduce the dosing frequency of antiretroviral regimens. Across a diverse, treatment-experienced cohort, we describe greatest interest in switching to an oral regimen taken once weekly, followed by inj...

Descripción completa

Detalles Bibliográficos
Autores principales: Derrick, Caroline B, Ostermann, Jan, Weissman, Sharon B, Hobbie, Amy, Alshareef, Noor, Weinhold, Andrew, Yelverton, Valerie, Thielman, Nathan M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6197380/
https://www.ncbi.nlm.nih.gov/pubmed/30364593
http://dx.doi.org/10.1093/ofid/ofy247
Descripción
Sumario:Study participants were asked about their interest in switching to novel drug delivery systems that reduce the dosing frequency of antiretroviral regimens. Across a diverse, treatment-experienced cohort, we describe greatest interest in switching to an oral regimen taken once weekly, followed by injections taken every other month and twice-annual implants.

Ejemplares similares